Financhill
Back

Macrogenics 10K Form

Sell
46

MGNX
Macrogenics

Last Price:
14.71
Seasonality Move:
34.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive MGNX News And Ratings

See the #1 stock for the next 7 days that we like better than MGNX

MGNX Financial Statistics

Sales & Book Value

Annual Sales: $57.19M
Cash Flow: $-28.66M
Price / Cash Flow: 0
Annual Sales: $2.46
Price / Book: 6.13

Profitability

EPS (TTM): -0.16000
Net Income (TTM): $-9.06M
Gross Margin: $48.97M
Return on Equity: -5.89%
Return on Assets: -2.89%

Macrogenics Earnings Forecast

Key Macrogenics Financial Ratios

  • The Gross Profit Margin over the past 9 years for MGNX is 85.62%.
  • The Selling, General & Administrative Expenses for MGNX have been equal to 91.25% of Gross Profit Margin.
  • The Research & Development expenses have been 291.26% of Revenue.
  • The Interest Expense is -15.79% of Operating Income.
  • The Net Earning history of MGNX is -15.84% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 7 years.

Macrogenics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: MGNX
CUSIP: 556099
Website: macrogenics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.48
Quick Ratio: 4.28

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MGNX Technical Analysis vs Fundamental Analysis

Sell
46
Macrogenics (MGNX) is a Sell

Is Macrogenics a Buy or a Sell?

  • Macrogenics stock is rated a Sell
    The current Macrogenics [MGNX] share price is $14.98. The Score for MGNX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.